Pharmather Hldgs Ltd (OP: PHRRF )
0.1000 +0.0050 (+5.26%) Streaming Delayed Price Updated: 2:52 PM EDT, Sep 26, 2023 Add to My Watchlist
Press Releases about Pharmather Hldgs Ltd
PharmaTher and Vitruvias Enter Into Collaboration Agreement for Commercialization of KETARX™ (racemic ketamine) in the U.S.
June 20, 2023
Expected FDA approval for KETARX™ (racemic ketamine) via the ANDA pathway in Q1-2024 and commercial launch in Q2-2024
PharmaTher Announces Poster Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease at Neuroscience 2022 by the Society for Neuroscience
November 14, 2022